Neuphoria Therapeutics Inc. Files Q3 2025 10-Q
Ticker: NEUP · Form: 10-Q · Filed: May 20, 2025 · CIK: 1191070
| Field | Detail |
|---|---|
| Company | Neuphoria Therapeutics Inc. (NEUP) |
| Form Type | 10-Q |
| Filed Date | May 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financial-reporting
TL;DR
Neuphoria Therapeutics filed its 10-Q for Q3 2025, showing financial updates and historical data.
AI Summary
Neuphoria Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Bionomics Limited, is in the pharmaceutical preparations sector. Key financial reporting periods include Q3 2025 and the fiscal year ending June 30, 2025. The filing also references events and financial data from 2021 through 2024, including details on equity incentive plans and warrants.
Why It Matters
This filing provides investors with an update on Neuphoria Therapeutics' financial health and operational status for the third quarter of fiscal year 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Neuphoria Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- Q3 2025 — Quarterly Period (Reporting period for this 10-Q filing.)
- 0630 — Fiscal Year End (Indicates the end of the company's fiscal year.)
Key Players & Entities
- Neuphoria Therapeutics Inc. (company) — Filer
- BIONOMICS LIMITED/FI (company) — Former Company Name
- 20250331 (date) — Period of Report
- 0630 (date) — Fiscal Year End
- 781-439-5551 (phone_number) — Business Phone
FAQ
What is the primary business of Neuphoria Therapeutics Inc.?
Neuphoria Therapeutics Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When was Neuphoria Therapeutics Inc. formerly known as?
Neuphoria Therapeutics Inc. was formerly known as BIONOMICS LIMITED/FI, with a date of name change on 20020920.
What is the reporting period for this 10-Q filing?
The conformed period of report for this 10-Q filing is 20250331, representing the quarter ending March 31, 2025.
Where is Neuphoria Therapeutics Inc. located?
Neuphoria Therapeutics Inc. is located at 100 Summit Dr, Burlington, MA 01803.
What are some of the financial reporting dates mentioned in the filing?
The filing references several dates including 2025-03-31, 2024-12-24, 2024-07-01, 2025-01-01, 2024-12-31, 2021-06-30, 2023-10-01, 2023-12-31, 2025-04-16, 2024-10-01, 2024-06-30, 2024-07-01, 2025-03-31, 2024-12-31, and 2023-09-30.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding Neuphoria Therapeutics Inc. (NEUP).